Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VETOFLEX Glucose is a veterinary intravenous solution developed and manufactured by Laboratoire Bioluz as part of their VETOFLEX® range of veterinary medicinal products. The active ingredient is dextrose (glucose), typically formulated as a 5% solution. This small molecule product is administered via the intravenous (IV) route to provide hydration along with caloric and energy support for veterinary patients requiring rehydration. Bioluz is a French pharmaceutical laboratory specializing in the manufacturing, filling, sterilization, and packaging of injectable solution bags for both human and veterinary use. The product is used across various animal species for fluid therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on VETOFLEX Glucose 5%.